Skip to Content
Home └Vedolizumab-4071_TWN_MV Plan_04 May 2026_Signed
Vedolizumab-4071_TWN_MV Plan_04 May 2026_Signed

Vedolizumab-4071_TWN_MV Plan_04 May 2026_Signed

Join this Course
Responsible Phoebe Chang 張渟湲
Last Update 05/20/2026
Completion Time 2 hours
Members 4